| Literature DB >> 35397392 |
Qi-Ming Pang1, Si-Yu Chen2, Qi-Jing Xu3, Meng Zhang2, Da-Fei Liang3, Sheng-Ping Fu1, Jiang Yu2, Zu-Lin Liu2, Qian Zhang4, Tao Zhang5.
Abstract
Spinal cord injury (SCI) is a catastrophic event which is still without adequate therapies. Neuroinflammation is the main pathogenesis of secondary damage post-SCI, leading to tissue loss and neurological dysfunction. Previous studies have shown that microglia and astrocytes are the major immune cells in the central nervous system (CNS) and play a crucial role in modulating neuroinflammatory responses. In this study, we mainly review the effects of neuroinflammation in SCI, focusing on the contributions of microglia and astrocytes and their cross-talk. Furthermore, we will also discuss therapeutic strategies on how to regulate their immunophenotype to suppress robust inflammation and facilitate injury prognosis.Entities:
Keywords: Astrocyte; Immunoregulation; Microglia; Neuroinflammation; Spinal cord injury
Mesh:
Year: 2022 PMID: 35397392 DOI: 10.1016/j.intimp.2022.108754
Source DB: PubMed Journal: Int Immunopharmacol ISSN: 1567-5769 Impact factor: 4.932